Clinical Trial Update: Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing precision dosing of infliximab to conventional dosing in inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Inflammatory Bowel Disease | Phase 4 | Status: COMPLETED